Faraday Future (NASDAQ:FFIE) reported quarterly losses of $(0.30) per share. This is a 71.7 percent increase over losses of $(1.06) per share from the same period last year.
Liminal BioSciences Announces Signature Of Share Purchase Agreement For Sale Of Remaining Plasma-Derived Business With Kedrion
Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), announced today that, Kedrion S.p.A ("Kedrion") has exercised its option to acquire the remainder of the
